# artesunate = as

### notes
+ prescription under medical supervision
+ oral artesunate must always be administered in combination with another antimalarial: artesunate-amodiaquine or artesunatemefloquine or artesunate-sulfadoxine/pyrimethamine. these therapeutic combinations can be coformulated tablets (artesunate and the 2nd antimalarial combined in the same tablet, in blister-pack containing a complete course of treatment) or co-blistered tablets (tablets of artesunate and tablets of the 2nd antimalarial in the same blister-pack containing a complete course of treatment). use coformulated tablets when available.

### therapeutic action
+ antimalarial

### indications
+ treatment of uncomplicated falciparum malaria
+ completion treatment following parenteral therapy for severe falciparum malaria

### presentation
+ 50 mg tablet

### dosage and duration
+ child and adult: 4 mg/kg/day once daily for 3 days

### contra-indications, adverse effects, precautions

+ may cause: gastrointestinal disturbances, headache and dizziness.
+ *pregnancy*: no contra-indication
+ *breast-feeding*: no contra-indication

### remarks
+ artesunate should not be used for malaria prophylaxis.
+ storage: below 25Â°c